Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.86B P/E 21.77 EPS this Y 47.10% Ern Qtrly Grth 35.40%
Income 499M Forward P/E 9.46 EPS next Y 25.60% 50D Avg Chg 5.00%
Sales 19.45B PEG 8.85 EPS past 5Y -11.94% 200D Avg Chg 27.00%
Dividend N/A Price/Book 0.99 EPS next 5Y 1.02% 52W High Chg -9.00%
Recommedations 3.80 Quick Ratio 0.91 Shares Outstanding 586.83M 52W Low Chg 97.00%
Insider Own - ROA 2.73% Shares Float 198.94M Beta 0.93
Inst Own 7.30% ROE 4.84% Shares Shorted/Prior 1.09M/1.33M Price 25.25
Gross Margin 25.32% Profit Margin 2.57% Avg. Volume 527,782 Target Price 18.66
Oper. Margin 9.93% Earnings Date - Volume 332,562 Change -2.25%
About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG News
04/23/24 Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last five years, but the stock soars 14% this past week
04/12/24 Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day
04/11/24 3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
04/10/24 Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
04/06/24 Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
10:10 AM Fresenius Medical (FMS) to Unveil Training on Augmented Reality
09:59 AM What Makes Fresenius Medical Care AG (FMS) a Potential Investment?
03/22/24 Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care
03/19/24 Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
03/11/24 Fresenius Medical (FMS) Divests Assets to Optimize Portfolio
03/09/24 Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.19
03/06/24 Health Care Roundup: Market Talk
03/05/24 Why Dialysis Stocks Are up Today
03/05/24 Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador
03/05/24 Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data
02/23/24 Fresenius Medical Care AG (ETR:FME) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
02/22/24 A Look At The Fair Value Of Fresenius Medical Care AG (ETR:FME)
02/21/24 Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2023 Earnings Call Transcript
02/21/24 Fresenius Swings to Net Loss After Fresenius Medical Care Deconsolidation
02/20/24 Fresenius Medical Care delivers on commitments in a year of fundamental transformation
FMS Chatroom

User Image Torp Posted - 1 day ago

@tarspro $FMS

User Image Torp Posted - 3 days ago

$ICU side note $FMS is up 5%

User Image Youngandhappy Posted - 3 days ago

$DVA $FMS $ICU $NUWE Belay that date Mateys. Some date after April 17, 2024, we learn the rest of the story……..that’s better! Fin. MB

User Image Youngandhappy Posted - 5 days ago

$ICU $NUWE $FMS $DVA $BAX CMO Dr. Kevin is a winner. Quelimmune SCD is a winner. The planet will soon be the biggest winner because of that combination. MB

User Image Youngandhappy Posted - 6 days ago

$ICU Board Member. Former CMO $FMS!!! Allan J. Collins, M.D., FACP is currently senior chief scientist and past chief medical officer of NxStage Fresenius Medical Care North America. Fresenius is the world's leading provider of products and services for people with chronic kidney failure. Dr. Collins is actively involved with several professional societies, including the National Kidney Foundation, where he served as president from 2006-2008, the International Society of Nephrology Commission for the Global Advancement of Nephrology, European Renal Association/European Dialysis and Transplant Association, and the NKF Kidney Dialysis Outcomes Quality Initiative. He was given the highest clinical honor, the Belding Scribner Award, from the American Society of Nephrology in 2015. He was the Director of the NIH's United States Renal Data System from 1999-2014. He is a renowned expert on kidney disease and dialysis, with more than 300 journal publications. MB

User Image barlaw Posted - 6 days ago

$CRMD $DVA and $FMS are both green today, with $SPY and $XBI both down. What does that tell ya?

User Image FutureOpt Posted - 1 week ago

$BAX $FMS $ICU They are giving us all the tips regarding a merger or a buyout. I was just about to post this 👇 Also check page 48 Load the boat!

User Image SideJobTrader Posted - 1 week ago

$ICU They didn't have to mention $FMS $BAX but they did? #MB

User Image ICU2025 Posted - 1 week ago

@MasheredTrader DVA is buying $RMTI I would bet on it If anyone buys $ICU I would bet it’s $FMS as they have a stake in the company and manufacture the device.

User Image rocketballer Posted - 1 week ago

$ICU $FMS Is a top player in the projected 186B market, and they are our partner, loves it.

User Image Profitfire Posted - 2 weeks ago

@Youngandhappy @Nmd_1980 $FMS slo could be possible and something will happens 100% from this level is again easily and fast possible with the right guys on their site 😏

User Image smartkarma Posted - 2 weeks ago

$FMS | Fresenius Medical Care: Initiation Of Coverage - Innovation with AR in Dialysis Training & 4 Other Major Drivers "Fresenius Medical Care's Q4 2023 earnings highlighted the progress made against their strategic plan that was set out a year prior. The plan..." - Baptista Research (Baptista Research) Key Points:Fresenius Medical Care's Q4 2023 earnings highlighted the progress made against their strategic plan that was set out a year prior.The plan focused on significant structural, operational and cultural changes, with the operating model being transformed at the start of 2023.This allowed the company to introduce a new financial report with increased transparency, which reflected a commitment to their operational turnaround initiatives that aided organic growth in both segments and improved operational performance. Read more: https://www.smartkarma.com/insights/fresenius-medical-care-initiation-of-coverage-innovation-with-ar-in-dialysis-training-4-other-major-drivers

User Image Youngandhappy Posted - 2 weeks ago

$ICU $NUWE $FMS $DVA 4 outfits ….thus far. April 17, 2024 we learn the whole story. MB

User Image Youngandhappy Posted - 3 weeks ago

$FMS April 17, 2024! AH! $ICU MB

User Image ICU2025 Posted - 03/31/24

$ICU happy Easter all, I see lots of buyout talk, it would be great if we could continue through 2026 and get a full year of sales. I do think $FMS wants us in the worst way, I would be shocked if they didn’t try to buy us out.

User Image LonnieSr1978 Posted - 03/26/24

$FMS $ICU Best post i've seen to date 🫡

User Image FatherofTrades Posted - 03/26/24

$ICU Most of us have been here for a few months at best. This has been bumpy for sure, but I really don’t know what everyone expected. A micro cap bio stock is going to be volatile, it’s going to fluctuate, and it’s going to be hammered by shorts to get their buddies in at discounted prices. That’s how the market works. Always has been. In fact, it used to be worse! There are people who are patient and reap the rewards, and there are people who saw someone cross post with 🚀🚀🚀🚀 and bought without doing DD. The latter will be chased out. When you complain, you’re just driving away new investors, and harming your wallet. Be HONEST AND TRANSPARENT if you want anyone to respect what you have to say. There are logistical hurdles here to cross, but given $FMS track record I’m not remotely concerned. Chances are, most people here are from the US. You won a lottery ticket being born here. Just think, you’re here complaining and a child in Gaza is hiding from gunfire. Perspective.

User Image jordalee Posted - 1 month ago

$ICU seems like the same framework $FMS would use for a partnership with us in the EU. What I find interesting is that this deal was signed before they had an approved product (last couple sentences in the last paragraph). Makes me more interested in what is going on behind the scenes for something like this.

User Image ICU2025 Posted - 1 month ago

@Blastus $DVA $FMS control market Where will the new players $RMTI $UNCY and possibly the biggest revenue wise $ICU end up in a couple years. It will be very interesting I think DVA and FMS will aggressively buy out all 3

User Image FatherofTrades Posted - 1 month ago

@Haha1978 Sufficient cash runway. Pediatric approval has been obtained and is being produced by $FMS now, adult AKI clinicals are in phase 2 which means most expenses are in the past. Right now they are sitting on an IP with many indications, and a very favorable manufacturing contract with $FMS, one of the largest dialysis providers in the world, so cash is not an issue as they can pay after units are sold.

User Image DailyStocksPicks Posted - 1 month ago

Today's Oversold Stock #4: Cabaletta Bio ($SHC): Sotera Health provides sterilization solutions, lab testing, and advisory services for the healthcare industry. Recently, it's faced challenges such as a secondary stock offering, insider selling, and disappointing earnings, which have pressured its stock price. These developments suggest the stock could be considered oversold, with the market potentially underestimating Sotera Health's value in its sector despite current challenges. $PGNY, $RDNT, $QGEN, $FMS For Detailed https://youtu.be/kiXj5yPn9rc

User Image GoodTidings Posted - 1 month ago

@scott52 There are loads of companies who would love to take $ICU over besides $FMS you got $BAX and $ABT ... These are just examples of giants in which this revolutionary proposition would fit into these giants business model!! 😃😃😃💪💪💪💸💸💸

User Image Stock_Titan Posted - 1 month ago

$FMS Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device https://www.stocktitan.net/news/FMS/fresenius-medical-care-launches-quot-augmented-reality-quot-for-zpp5ddukoo0h.html

User Image Youngandhappy Posted - 1 month ago

@cakegladiator I like to fantasize. Sepsis cure. Dialysis partner $FMS is losing 40-60% of their business in 5-10 years. Heart, lung, autoimmune, Lyme, all are hyper inflammatory responses. Cancer is a hyper inflammatory response. I think $1125 is the 2035 #, unless there are splits. $15 eoy.

User Image FatherofTrades Posted - 1 month ago

@Guapodrew @rockystar996 I’m trying! I OBVIOUSLY want a MC like $FMS but it just doesnt happen overnight. The scientists at ICU have done the hard work already. The easy part is sitting and waiting. Bio DOES explode sometimes, but let’s be real, we don’t know when. I’m fine with that.

User Image lobezna Posted - 1 month ago

$FMS Buy the dip!!!

User Image lobezna Posted - 1 month ago

$FMS Just testing my ability on trading predictions. According to my algorithm, it’s a “Buy Now” and sell when it reaches $23-25. Let’s see.

User Image EnterpriseValue20 Posted - 1 month ago

$FMS $ICU And they have $$$$ to spare

User Image oldjimzimmer Posted - 1 month ago

$ICU looks like the SCD fitted to a $FMS NxStage machine. Behind them is the $NUWE Aquadex booth 🧐 $ICUCW $NUWEW

User Image Torp Posted - 1 month ago

$ICU we need to get $FMS investors in here. Are there any?

Analyst Ratings
HSBC Hold Nov 24, 23
Truist Securities Hold Oct 11, 23
Truist Securities Hold Jul 13, 23
Truist Securities Hold May 10, 23
Truist Securities Hold Apr 13, 23
Truist Securities Hold Feb 23, 23
Truist Securities Hold Jun 22, 22
HSBC Hold Nov 23, 21
RBC Capital Sector Perform Nov 17, 21